GL1X · GenesisL1 explorer

Research workbench

Traptavidin, apo-form

Analyse Traptavidin, apo-form in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2Y3E
Type
protein
Length
240 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Streptavidin
UniProt
P22629
Pockets
2 · best druggability 0.47

Structure

x-ray diffraction · 1 distinct chain · 3% helix, 57% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BStreptavidinprotein1203% helix, 57% strandP22629

Ligands and binding sites

  • GOL · Glycerol · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1850.470.8118GOL
2950.460.8019GOL

Interfaces

1 interface between chains.

  • A–B · 1597 Ų buried · 32 hydrogen bonds · protein-protein

Compared structures

  • 2Y3E · Traptavidin, apo-form · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.